$NBIX news
The latest NBIX stock news: headlines, filings, AI summaries and sentiment for $NBIX, updated around the clock.
- Xenon Pharmaceuticals Reports Q3 2026 Financial Results and Azetukalner FDA Submission
- Neurocrine Biosciences Shares Rise 13% Following Q3 Earnings Beat and Raised Guidance
- Neurocrine Biosciences Shares Surge Following Q3 Revenue Beat and Raised Guidance
- Neurocrine Biosciences Reports Q3 2026 Record Revenue and Raised INGREZZA Guidance
- Neurocrine Biosciences Reports Record Q3 Sales Driven by INGREZZA
- Neurocrine Biosciences Reports Q3 Earnings Beat and Raises Ingrezza Sales Guidance
- NEUROCRINE BIOSCIENCES INC - 10-Q Filing
- NEUROCRINE BIOSCIENCES INC - 8-K Filing
- NEUROCRINE BIOSCIENCES INC - 8-K Filing
- Neurocrine Biosciences Reports Positive INGREZZA Data and Strong Q2 Results
- Fundstrat Capital Completes August 2026 Rebalance for Granny Shots ETFs
- Fundstrat Granny Shots ETF Adds Allient and Others in Quarterly Portfolio Revision
- Neurocrine Biosciences Reports Strong Q2 2026 Performance and Strategic Growth
- NEUROCRINE BIOSCIENCES INC - 8-K Filing
- NEUROCRINE BIOSCIENCES INC - 10-Q Filing
- Neurocrine Biosciences Reports Q2 2026 Earnings with Strong Revenue Growth
- NEUROCRINE BIOSCIENCES INC - 8-K Filing
- Neurocrine Shares Rise on Strong Sales Growth and Positive Institutional Inflows
- Crinetics Pharmaceuticals Shares Surge Over 99% on $10 Billion Acquisition Deal with Vertex
- RBC Capital Raises Price Target on Neurocrine Biosciences
- Soleus Capital Adds $63M to Vericel Stake Amid Revenue Growth
- Neurocrine Biosciences Shares Reach Record High Following Strong Earnings Report
- NEUROCRINE BIOSCIENCES INC - 8-K Filing
- Neurocrine Biosciences Reports Q1 2026 Earnings Exceeding $800 Million in Net Product Sales
- Neurocrine Biosciences Announces Two-Year Data from Phase 3 CAHtalyst Adult Study